Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockade
Authors:
- 1 March 2009
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 68 (3) , 362-366
Abstract
Objectives: Ankylosing spondylitis (AS) is associated with increased cardiovascular morbidity and mortality. Microvascular function has been linked to several risk factors for cardiovascular disease. Inflammation in AS may cause microvascular dysfunction. To test this, we assessed microvascular function in (a) patients with AS compared to healthy controls and (b) patients with AS before and after 1 month of anti-tumour necrosis factor (TNF)α treatment with etanercept. Methods: A total of 15 consecutive patients with AS, who were scheduled for etanercept treatment according to the Assessment in Ankylosing Spondylitis (ASAS) group guidelines, and 12 healthy controls matched for age and sex, were recruited. Endothelium-dependent and independent vasodilatation in skin were evaluated with laser Doppler fluxmetry after iontophoresis of acetylcholine and sodium nitroprusside, respectively. Videomicroscopy was used to measure recruitment of skin capillaries after arterial occlusion. Results: Compared to healthy controls, patients with AS had impaired endothelium-dependent vasodilatation and capillary recruitment. Following anti-TNFα treatment, microvascular function improved significantly for endothelium-dependent vasodilatation (p = 0.03) and capillary recruitment (p = 0.006). A significant correlation was observed between changes in endothelium-dependent vasodilatation and changes in erythrocyte sedimentation rate (ESR) (r = −0.56; p = 0.03). Conclusion: Microvascular dysfunction is present in patients with AS with active disease, but improves as inflammation regresses after TNFα blockade.Keywords
This publication has 45 references indexed in Scilit:
- Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitisAtherosclerosis, 2008
- Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factorsArthritis Care & Research, 2007
- Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2006
- Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritisAtherosclerosis, 2006
- Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long‐term treatment with anti–tumor necrosis factor α antibodyArthritis Care & Research, 2004
- Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjectsArthritis & Rheumatism, 2003
- Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?Arthritis & Rheumatism, 2002
- Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donorsArthritis & Rheumatism, 1998
- Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDMDiabetologia, 1995
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984